z-logo
open-access-imgOpen Access
Pharmacoeconomic evaluation of ceftazidime + avibactam administration in the treatment of nosocomial pneumonia caused by carbapenem-resistant Enterobacteriacea and complicated by bacteremia
Author(s) -
S. К. Zyryanov,
I. N. Dyakov
Publication year - 2020
Publication title -
medicinskie tehnologii. ocenka i vybor
Language(s) - English
Resource type - Journals
eISSN - 2712-7877
pISSN - 2219-0678
DOI - 10.17116/medtech20204002150
Subject(s) - ceftazidime/avibactam , bacteremia , medicine , ceftazidime , pneumonia , carbapenem , intensive care medicine , avibactam , antibiotics , microbiology and biotechnology , pseudomonas aeruginosa , biology , bacteria , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here